Investigational Drugs Available

At Bristol-Myers Squibb, we are doing everything we can to ensure that patients with serious or life-threatening diseases receive the benefit of our innovative medicines as quickly as possible. We welcome requests for early patient access from the physicians treating these patients.

Submitting a Request Form

Request forms must be submitted by the healthcare professional. Patient eligibility will be determined by Bristol-Myers Squibb in accordance with established policies and procedures. Bristol-Myers Squibb’s acceptance and processing of this application does not guarantee that access to the investigational product will be provided.

Current Programs: Early Patient Access (EPA) Programs

Elotuzumab (BMS-901608)

Triangle Icon

Nivolumab (BMS-936558)

Triangle Icon

Early Patient Access Request (Other Products)

Triangle Icon